Words of wisdom. Re: Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.
Department of Urology, MD Anderson Cancer Center, Houston, TX, USA.
Patrick A
PA
Kenney
Christopher G
CG
Wood